HES Valais’ Economic Research and...
EraCal Therapeutics, the Biotech Company Developing Solutions to Different Diseases, Joins SFNV
EraCal Therapeutics, the Biotech Company Developing Solutions to Different Diseases, Joins SFNV
The preclinical biotech startup, EraCal Therapeutics, which develops drugs using cutting-edge science to treat health and obesity issues, has joined the SFNV.
Switzerland, February 2021 – EraCal Therapeutics, a Swiss producer of biotechnology drugs using cutting-edge technology to treat metabolic syndrome, has joined the SFNV. The company is currently focusing on a pipeline of appetite suppressants to tackle obesity and its metabolic complications. Its lead molecule, Era-107, is an oral appetite suppressor with superior efficacy and safety profile, as demonstrated in three vertebrate species. EraCal is now preparing to carry out further toxicology studies ahead of first-in-human trials.
For more information:
E-mail : info@eracal.ch
Latest Members
L’Institut d’Entrepreneuriat et de Management, the Economic Research and Development Center Associated to HES Valais, Joins SFNV
Sight and Life Foundation, the Humanitarian Nutrition Think Tank Working to End Malnutrition, Joins SFNV
The Swiss-based foundation, Sight and...
Nemis Technologies, the Startup Transforming Food Pathogen Testing, Joins SFNV
The biotech startup, Nemis...